Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy

Lignende værker

• Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network Trials S0106 and S1203
  af: Moseley, Anna, et al.
  Udgivet: (2021)
• Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia
  af: Medeiros, Bruno C., et al.
  Udgivet: (2015)
• Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies
  af: Othus, Megan, et al.
  Udgivet: (2018)
• Influence of Obesity on Efficacy and Toxicity of Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
  af: Lin, Andrew, et al.
  Udgivet: (2012)
• Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
  af: Othus, Megan, et al.
  Udgivet: (2016)